Gilenya and Headache - a phase IV clinical study of FDA data
Summary:
Headache is reported as a side effect among people who take Gilenya (fingolimod), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Vitamin D, and have Pain.
The phase IV clinical study analyzes which people have Headache when taking Gilenya. It is created by eHealthMe based on reports of 111,612 people who have side effects when taking Gilenya from the FDA, and is updated regularly.
What is Gilenya?
Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 111,893 Gilenya users. Check the latest studies of Gilenya.
What is Headache?
Headache (pain in head) is found to be associated with 3,753 drugs and 5,772 conditions by eHealthMe. Check the latest studies of Headache.
111,612 people reported to have side effects when taking Gilenya.
Among them, 10,907 people (9.77%) have Headache.
Among these 10,907 people:
How long have people been on Gilenya when they have Headache? *
What is the gender of people who have Headache when taking Gilenya? *
What is the age of people who have Headache when taking Gilenya? *
What are other drugs people take besides Gilenya? *
What are other side effects people have besides Headache? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Gilenya and have Headache?
- Check whether Headache is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Gilenya:
- Gilenya (111,893 reports)
Headache treatments and more:
- Headache (756,642 reports)
How severe was Headache and when was it recovered:
Expand to all the drugs that have ingredients of fingolimod:
- Headache and drugs with ingredients of fingolimod (11,028 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gilenya:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Headache:
- Headache (3,753 drugs)
Browse all the conditions that are associated with Headache:
- Headache (5,772 conditions)
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Alroughani R, "Fingolimod-associated amenorrhea: a report of three cases", Multiple Sclerosis Journal, 2014 Jan .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Alroughani R, "Fingolimod-associated amenorrhea: a report of three cases", Multiple Sclerosis Journal, 2014 Jan .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on fingolimod (the active ingredients of Gilenya) and Gilenya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Melatonin cause Blindness? - 8 seconds ago
- Drug interactions of Itraconazole and Sulfadiazine - 27 seconds ago
- Drug interactions of Cabergoline and Metoclopramide - 31 seconds ago
- Could Venlafaxine Hydrochloride cause Asthma Aggravated? - 59 seconds ago
- Could Vitamin E cause Drowsiness? - 59 seconds ago
- Drug interactions of Celebrex and Senna - a minute ago
- Could Methotrexate cause Electrolyte Imbalance? - a minute ago
- Stress And Anxiety and Leukocytosis - a minute ago
- Could Vitamin K cause Speech Impairment (Adult)? - a minute ago
- Could Doxycycline Hyclate cause Coughing Up Blood? - 2 minutes ago